APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intramuscular Injection of Pain Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intramuscular Injection of Pain Medication Industry Growth and Trends Forecast to 2032

23 December 2025114 pages

Choose your research edition.

Industry ResearchIntramuscular Injection of Pain Medication Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Intramuscular Injection of Pain Medication Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intramuscular Injection of Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intramuscular Injection of Pain Medication Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Intramuscular Injection of Pain Medication Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Intramuscular Injection of Pain Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intramuscular Injection of Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Intramuscular Injection of Pain Medication market include Yangtze River Pharmaceutical Group (YRPG), Shijiazhuang Pharmaceutical Group, Sanofi, Humanwell Healthcare, Qilu Pharmaceutical, Novartis, Merck, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intramuscular Injection of Pain Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intramuscular Injection of Pain Medication market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intramuscular Injection of Pain Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intramuscular Injection of Pain Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Intramuscular Injection of Pain Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intramuscular Injection of Pain Medication Market by Company

Yangtze River Pharmaceutical Group (YRPG)

Shijiazhuang Pharmaceutical Group

Sanofi

Humanwell Healthcare

Qilu Pharmaceutical

Novartis

Merck

Roche

Pfizer

China Resources Double Crane

Hengrui Medicine

Sinopharm Group

Fresenius Kabi

Northeast Pharmaceuticals

AstraZeneca

Hikma Pharmaceuticals

Grünenthal

Intramuscular Injection of Pain Medication Segment by Type

Opioid Analgesics (Opioids)

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Local Anesthetics

Others

Intramuscular Injection of Pain Medication Segment by Application

Hospital

Clinic

Others

Intramuscular Injection of Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intramuscular Injection of Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intramuscular Injection of Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intramuscular Injection of Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Intramuscular Injection of Pain Medication companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Intramuscular Injection of Pain Medication Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Intramuscular Injection of Pain Medication Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Intramuscular Injection of Pain Medication Market Share by Region (2021-2026) Table 4. Global Intramuscular Injection of Pain Medication Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Intramuscular Injection of Pain Medication Market Share by Region (2027-2032) Table 6. Global Intramuscular Injection of Pain Medication Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Intramuscular Injection of Pain Medication Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2026) Table 9. Global Intramuscular Injection of Pain Medication Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Intramuscular Injection of Pain Medication Market Size Share Forecasted by Type (2027-2032) Table 11. North America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Intramuscular Injection of Pain Medication Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Intramuscular Injection of Pain Medication Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2026) Table 24. Global Intramuscular Injection of Pain Medication Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Intramuscular Injection of Pain Medication Market Size Share Forecasted by Application (2027-2032) Table 26. North America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Intramuscular Injection of Pain Medication Industry Trends Table 37. Intramuscular Injection of Pain Medication Industry Drivers Table 38. Intramuscular Injection of Pain Medication Industry Opportunities and Challenges Table 39. Intramuscular Injection of Pain Medication Industry Restraints Table 40. Global Intramuscular Injection of Pain Medication Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Intramuscular Injection of Pain Medication Revenue Market Share by Company (2021-2026) Table 42. Global Intramuscular Injection of Pain Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Intramuscular Injection of Pain Medication Key Company Headquarters & Area Served Table 44. Global Intramuscular Injection of Pain Medication Company, Product Type & Application Table 45. Global Intramuscular Injection of Pain Medication Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Intramuscular Injection of Pain Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Yangtze River Pharmaceutical Group (YRPG) Company Information Table 49. Yangtze River Pharmaceutical Group (YRPG) Business Overview Table 50. Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Product Portfolio Table 52. Yangtze River Pharmaceutical Group (YRPG) Recent Development Table 53. Shijiazhuang Pharmaceutical Group Company Information Table 54. Shijiazhuang Pharmaceutical Group Business Overview Table 55. Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Product Portfolio Table 57. Shijiazhuang Pharmaceutical Group Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Intramuscular Injection of Pain Medication Product Portfolio Table 62. Sanofi Recent Development Table 63. Humanwell Healthcare Company Information Table 64. Humanwell Healthcare Business Overview Table 65. Humanwell Healthcare Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Humanwell Healthcare Intramuscular Injection of Pain Medication Product Portfolio Table 67. Humanwell Healthcare Recent Development Table 68. Qilu Pharmaceutical Company Information Table 69. Qilu Pharmaceutical Business Overview Table 70. Qilu Pharmaceutical Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Qilu Pharmaceutical Intramuscular Injection of Pain Medication Product Portfolio Table 72. Qilu Pharmaceutical Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Intramuscular Injection of Pain Medication Product Portfolio Table 77. Novartis Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck Intramuscular Injection of Pain Medication Product Portfolio Table 82. Merck Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Intramuscular Injection of Pain Medication Product Portfolio Table 87. Roche Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Intramuscular Injection of Pain Medication Product Portfolio Table 92. Pfizer Recent Development Table 93. China Resources Double Crane Company Information Table 94. China Resources Double Crane Business Overview Table 95. China Resources Double Crane Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. China Resources Double Crane Intramuscular Injection of Pain Medication Product Portfolio Table 97. China Resources Double Crane Recent Development Table 98. Hengrui Medicine Company Information Table 99. Hengrui Medicine Business Overview Table 100. Hengrui Medicine Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hengrui Medicine Intramuscular Injection of Pain Medication Product Portfolio Table 102. Hengrui Medicine Recent Development Table 103. Sinopharm Group Company Information Table 104. Sinopharm Group Business Overview Table 105. Sinopharm Group Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sinopharm Group Intramuscular Injection of Pain Medication Product Portfolio Table 107. Sinopharm Group Recent Development Table 108. Fresenius Kabi Company Information Table 109. Fresenius Kabi Business Overview Table 110. Fresenius Kabi Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Fresenius Kabi Intramuscular Injection of Pain Medication Product Portfolio Table 112. Fresenius Kabi Recent Development Table 113. Northeast Pharmaceuticals Company Information Table 114. Northeast Pharmaceuticals Business Overview Table 115. Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio Table 117. Northeast Pharmaceuticals Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AstraZeneca Intramuscular Injection of Pain Medication Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Hikma Pharmaceuticals Company Information Table 124. Hikma Pharmaceuticals Business Overview Table 125. Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio Table 127. Hikma Pharmaceuticals Recent Development Table 128. Grünenthal Company Information Table 129. Grünenthal Business Overview Table 130. Grünenthal Intramuscular Injection of Pain Medication Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Grünenthal Intramuscular Injection of Pain Medication Product Portfolio Table 132. Grünenthal Recent Development Table 133. North America Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Intramuscular Injection of Pain Medication Market Share by Country (2021-2026) Table 136. North America Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Intramuscular Injection of Pain Medication Market Share Forecast by Country (2027-2032) Table 138. Europe Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Intramuscular Injection of Pain Medication Market Share by Country (2021-2026) Table 141. Europe Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Intramuscular Injection of Pain Medication Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Intramuscular Injection of Pain Medication Market Share by Country (2021-2026) Table 146. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Intramuscular Injection of Pain Medication Market Share Forecast by Country (2027-2032) Table 148. Latin America Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Intramuscular Injection of Pain Medication Market Share by Country (2021-2026) Table 151. Latin America Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Intramuscular Injection of Pain Medication Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Country (2021-2026) Table 156. Middle East & Africa Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Intramuscular Injection of Pain Medication Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Intramuscular Injection of Pain Medication Product Image Figure 3. Global Intramuscular Injection of Pain Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Intramuscular Injection of Pain Medication Market Size (2021-2032) & (US$ Million) Figure 5. Global Intramuscular Injection of Pain Medication Market Share by Region: 2025 VS 2032 Figure 6. Global Intramuscular Injection of Pain Medication Market Share by Region (2021-2032) Figure 7. North America Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Opioid Analgesics (Opioids) Image Figure 13. Global Opioid Analgesics (Opioids) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Image Figure 15. Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Local Anesthetics Image Figure 17. Global Local Anesthetics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Intramuscular Injection of Pain Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Intramuscular Injection of Pain Medication Market Share by Type 2025 VS 2032 Figure 22. North America Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032) Figure 23. Europe Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032) Figure 25. Latin America Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Intramuscular Injection of Pain Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Intramuscular Injection of Pain Medication Market Share by Application 2025 VS 2032 Figure 35. North America Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032) Figure 36. Europe Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032) Figure 38. Latin America Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Intramuscular Injection of Pain Medication Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Intramuscular Injection of Pain Medication Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Intramuscular Injection of Pain Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Intramuscular Injection of Pain Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 45. Europe Intramuscular Injection of Pain Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Intramuscular Injection of Pain Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 48. Asia-Pacific Intramuscular Injection of Pain Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Intramuscular Injection of Pain Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 51. Latin America Intramuscular Injection of Pain Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Intramuscular Injection of Pain Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 54. Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Intramuscular Injection of Pain Medication Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Analgesics (Opioids)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Yangtze River Pharmaceutical Group (YRPG)
  • Shijiazhuang Pharmaceutical Group
  • Sanofi
  • Humanwell Healthcare
  • Qilu Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • China Resources Double Crane
  • Hengrui Medicine
  • Sinopharm Group
  • Fresenius Kabi
  • Northeast Pharmaceuticals
  • AstraZeneca
  • Hikma Pharmaceuticals
  • Grünenthal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Intramuscular Injection of Pain Medication Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Intramuscular Injection of Pain Medication Market Size by Region (2021-2032)
  5. 1.4.1 Global Intramuscular Injection of Pain Medication Market Size by Region (2021-2026)
  6. 1.4.2 Global Intramuscular Injection of Pain Medication Market Size by Region (2027-2032)
  7. 1.5 Key Regions Intramuscular Injection of Pain Medication Market Size (2021-2032)
  8. 1.5.1 North America Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Intramuscular Injection of Pain Medication Market Size Growth Rate (2021-2032)
2 Intramuscular Injection of Pain Medication Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Opioid Analgesics (Opioids)
  3. 2.1.2 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  4. 2.1.3 Local Anesthetics
  5. 2.1.4 Others
  6. 2.2 Global Intramuscular Injection of Pain Medication Market Size by Type
  7. 2.2.1 Global Intramuscular Injection of Pain Medication Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Intramuscular Injection of Pain Medication Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Intramuscular Injection of Pain Medication Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Intramuscular Injection of Pain Medication Market Size by Regions
  11. 2.3.1 North America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Type (2021-2026)
3 Intramuscular Injection of Pain Medication Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Intramuscular Injection of Pain Medication Market Size by Application
  6. 3.2.1 Global Intramuscular Injection of Pain Medication Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Intramuscular Injection of Pain Medication Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Intramuscular Injection of Pain Medication Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Intramuscular Injection of Pain Medication Market Size by Regions
  10. 3.3.1 North America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Intramuscular Injection of Pain Medication Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Intramuscular Injection of Pain Medication Industry Trends
  2. 4.2 Intramuscular Injection of Pain Medication Industry Drivers
  3. 4.3 Intramuscular Injection of Pain Medication Industry Opportunities and Challenges
  4. 4.4 Intramuscular Injection of Pain Medication Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Intramuscular Injection of Pain Medication Revenue (2021-2026)
  2. 5.2 Global Intramuscular Injection of Pain Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Intramuscular Injection of Pain Medication Key Company Headquarters & Area Served
  4. 5.4 Global Intramuscular Injection of Pain Medication Company, Product Type & Application
  5. 5.5 Global Intramuscular Injection of Pain Medication Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Intramuscular Injection of Pain Medication Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Intramuscular Injection of Pain Medication Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Intramuscular Injection of Pain Medication Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Yangtze River Pharmaceutical Group (YRPG)
  2. 6.1.1 Yangtze River Pharmaceutical Group (YRPG) Company Information
  3. 6.1.2 Yangtze River Pharmaceutical Group (YRPG) Business Overview
  4. 6.1.3 Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Yangtze River Pharmaceutical Group (YRPG) Intramuscular Injection of Pain Medication Product Portfolio
  6. 6.1.5 Yangtze River Pharmaceutical Group (YRPG) Recent Developments
  7. 6.2 Shijiazhuang Pharmaceutical Group
  8. 6.2.1 Shijiazhuang Pharmaceutical Group Company Information
  9. 6.2.2 Shijiazhuang Pharmaceutical Group Business Overview
  10. 6.2.3 Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Shijiazhuang Pharmaceutical Group Intramuscular Injection of Pain Medication Product Portfolio
  12. 6.2.5 Shijiazhuang Pharmaceutical Group Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Intramuscular Injection of Pain Medication Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Humanwell Healthcare
  20. 6.4.1 Humanwell Healthcare Company Information
  21. 6.4.2 Humanwell Healthcare Business Overview
  22. 6.4.3 Humanwell Healthcare Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Humanwell Healthcare Intramuscular Injection of Pain Medication Product Portfolio
  24. 6.4.5 Humanwell Healthcare Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Intramuscular Injection of Pain Medication Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Intramuscular Injection of Pain Medication Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck Intramuscular Injection of Pain Medication Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Intramuscular Injection of Pain Medication Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Intramuscular Injection of Pain Medication Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 China Resources Double Crane
  56. 6.10.1 China Resources Double Crane Company Information
  57. 6.10.2 China Resources Double Crane Business Overview
  58. 6.10.3 China Resources Double Crane Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 China Resources Double Crane Intramuscular Injection of Pain Medication Product Portfolio
  60. 6.10.5 China Resources Double Crane Recent Developments
  61. 6.11 Hengrui Medicine
  62. 6.11.1 Hengrui Medicine Company Information
  63. 6.11.2 Hengrui Medicine Business Overview
  64. 6.11.3 Hengrui Medicine Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hengrui Medicine Intramuscular Injection of Pain Medication Product Portfolio
  66. 6.11.5 Hengrui Medicine Recent Developments
  67. 6.12 Sinopharm Group
  68. 6.12.1 Sinopharm Group Company Information
  69. 6.12.2 Sinopharm Group Business Overview
  70. 6.12.3 Sinopharm Group Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sinopharm Group Intramuscular Injection of Pain Medication Product Portfolio
  72. 6.12.5 Sinopharm Group Recent Developments
  73. 6.13 Fresenius Kabi
  74. 6.13.1 Fresenius Kabi Company Information
  75. 6.13.2 Fresenius Kabi Business Overview
  76. 6.13.3 Fresenius Kabi Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Fresenius Kabi Intramuscular Injection of Pain Medication Product Portfolio
  78. 6.13.5 Fresenius Kabi Recent Developments
  79. 6.14 Northeast Pharmaceuticals
  80. 6.14.1 Northeast Pharmaceuticals Company Information
  81. 6.14.2 Northeast Pharmaceuticals Business Overview
  82. 6.14.3 Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Northeast Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio
  84. 6.14.5 Northeast Pharmaceuticals Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca Intramuscular Injection of Pain Medication Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Intramuscular Injection of Pain Medication Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Grünenthal
  98. 6.17.1 Grünenthal Company Information
  99. 6.17.2 Grünenthal Business Overview
  100. 6.17.3 Grünenthal Intramuscular Injection of Pain Medication Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Grünenthal Intramuscular Injection of Pain Medication Product Portfolio
  102. 6.17.5 Grünenthal Recent Developments
7 North America
  1. 7.1 North America Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  3. 7.3 North America Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  3. 8.3 Europe Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  3. 10.3 South America Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Intramuscular Injection of Pain Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Intramuscular Injection of Pain Medication Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Intramuscular Injection of Pain Medication Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst